GENENTA SCIENCE SPA - ADR (GNTA) Stock Income Statement
USA - NASDAQ:GNTA - US36870W1009 - ADR
2.57 USD
-0.3 (-10.45%)
2.6 USD
+0.03 (+1.17%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 9.76M | 11.73M | 11.04M | 5.69M | 5.59M | |||
| Research and Development | 4.81M | 6.47M | 5.34M | 3.39M | 4.69M | |||
| Selling, General, and Administrative Expenses | 4.95M | 5.26M | 5.71M | 2.30M | 900.00K | |||
| Operating Income | -9.76M | -11.73M | -11.04M | -5.69M | -5.59M | |||
| Interest Income/Expense | 322.10K | 92.40K | 40.00K | -10.00K | -10.00K | |||
| Other Income/Expense | 529.70K | -4.90K | 2.53M | 170.00K | 10.00K | |||
| Income Before Taxes | -8.91M | -11.65M | -8.48M | -5.53M | -5.59M | |||
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -8.91M | -11.65M | -8.48M | -5.53M | -5.59M | |||
| EBITDA | -9.72M | -11.69M | -11.03M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.49 | -0.64 | -0.47 | -0.30 | -0.31 | |||
| Statistics | ||||||||
All data in EUR